A peptidomimetic siRNA transfection reagent for highly effective gene silencing.

RNA interference (RNAi) techniques hold forth great promise for therapeutic silencing of deleterious genes. However, clinical applications of RNAi require the development of safe and efficient methods for intracellular delivery of small interfering RNA (siRNA) oligonucleotides specific to targeted genes. We describe the use of a lipitoid, a cationic oligopeptoid-phospholipid conjugate, for non-viral transfection of synthetic siRNA oligos in cell culture. This peptidomimetic delivery vehicle allows for efficient siRNA transfection in a variety of human cell lines with negligible toxicity and promotes extensive downregulation of the targeted genes at both the protein and the mRNA level. We compare the lipitoid reagent to a standard commercial transfection reagent. The lipitoid is highly efficient even in primary IMR-90 human lung fibroblasts in which other commercial reagents are typically ineffective.

[1]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[2]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[3]  David R Corey,et al.  RNA interference in mammalian cells by chemically-modified RNA. , 2003, Biochemistry.

[4]  Bernd Jagla,et al.  Sequence characteristics of functional siRNAs. , 2005, RNA.

[5]  Annelise E Barron,et al.  Mimicry of bioactive peptides via non-natural, sequence-specific peptidomimetic oligomers. , 2002, Current opinion in chemical biology.

[6]  J. Lieberman,et al.  An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection , 2006, Nature.

[7]  Walter H. Moos,et al.  Comparison of the proteolytic susceptibilities of homologous L‐amino acid, D‐amino acid, and N‐substituted glycine peptide and peptoid oligomers , 1995 .

[8]  F. Cohen,et al.  A combinatorial approach to the discovery of efficient cationic peptoid reagents for gene delivery. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Gellman,et al.  Effects of side chain configuration and backbone spacing on the gene delivery properties of lysine-derived cationic polymers. , 2005, Bioconjugate chemistry.

[10]  Matthias John,et al.  Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells. , 2004, Bioorganic & medicinal chemistry letters.

[11]  T. Tuschl,et al.  RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.

[12]  Andrew D. Miller,et al.  Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. , 2004, Biochemistry.

[13]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[14]  Matthias John,et al.  RNAi-mediated gene silencing in non-human primates , 2006, Nature.

[15]  W. W. Nichols,et al.  Characterization of a new human diploid cell strain, IMR-90. , 1977, Science.

[16]  R. Zuckermann,et al.  Structure/function analysis of peptoid/lipitoid:DNA complexes. , 2003, Journal of pharmaceutical sciences.

[17]  D. Lewis,et al.  A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  Matthias John,et al.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.

[19]  R. Griffey,et al.  Positional effect of chemical modifications on short interference RNA activity in mammalian cells. , 2005, Journal of Medicinal Chemistry.

[20]  F. Cohen,et al.  Lipitoids--novel cationic lipids for cellular delivery of plasmid DNA in vitro. , 1998, Chemistry & biology.

[21]  Hideyoshi Harashima,et al.  RNA interference induced by siRNAs modified with 4′‐thioribonucleosides in cultured mammalian cells , 2005, FEBS letters.

[22]  M. Bradley,et al.  Cell penetrable peptoid carrier vehicles: synthesis and evaluation. , 2003, Chemical communications.

[23]  Stephen B. H. Kent,et al.  Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis , 1992 .

[24]  G. Hannon,et al.  Unlocking the potential of the human genome with RNA interference , 2004, Nature.